Follow-up for pregnant women during the COVID-19 pandemic: French national authority for health recommendations.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 15 5 2020
medline: 4 9 2020
entrez: 15 5 2020
Statut: ppublish

Résumé

In the context of the stage 3 SARS-Cov-2 epidemic situation, it is necessary to put forward a method of rapid response for an HAS position statement in order to answer to the requests from the French Ministry of Solidarity and Health, healthcare professionals and/or health system users' associations concerning follow-up of pregnant women during the COVID-19 outbreak. A simplified 7-step process that favours HAS collaboration with experts (healthcare professionals, health system users' associations, scientific societies etc.), the restrictive selection of available evidence and the use of digital means of communication. A short and specific dissemination format, which can be quickly updated in view of the changes in available data has been chosen.

Identifiants

pubmed: 32407897
pii: S2468-7847(20)30147-1
pii: S2468-7847(20)30147-1
doi: 10.1016/j.jogoh.2020.101804
pmc: PMC7212959
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

101804

Informations de copyright

© 2020 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no competing interests

Références

Ultrasound Obstet Gynecol. 2020 Jun;55(6):871-878
pubmed: 32267981
Gynecol Obstet Fertil Senol. 2020 May;48(5):436-443
pubmed: 32199996
Am J Perinatol. 2020 Jun;37(8):773-779
pubmed: 32303077
Gynecol Obstet Fertil. 2008 Jan;36(1):111-4
pubmed: 18323004
N Engl J Med. 2020 May 28;382(22):2163-2164
pubmed: 32283004
Acta Obstet Gynecol Scand. 2020 Jul;99(7):823-829
pubmed: 32259279

Auteurs

Alexandre J Vivanti (AJ)

Service de Gynécologie Obstétrique, Hôpital Antoine Béclère, AP-HP, Université Paris-Saclay, 92140 Clamart, France. Electronic address: alexandre.vivanti@aphp.fr.

Philippe Deruelle (P)

Collège National des Gynécologues Obstétriciens Français, 75002 Paris, France; Service de Gynécologie Obstétrique, Hôpital de Hautepierre, Faculté de Médecine de Strasbourg, 67000 Strasbourg, France.

Olivier Picone (O)

Collège National des Gynécologues Obstétriciens Français, 75002 Paris, France; Division of Obstetrics and Gynecology, "Louis Mourier" Hospital, Paris University, IAME INSERM U1137, APHP (Paris, France) GRIG (Groupe de Recherche sur les Infections pendant la Grossesse), 92700 Colombes.

Sophie Guillaume (S)

Collège National des Sages-Femmes de France, 75015 Paris, France.

Jean-Christophe Roze (JC)

Conseil National des Professionnels de Pédiatrie, 75015 Paris, France.

Blandine Mulin (B)

French Federation of Perinatal Health Networks, 31000 Toulouse, France.

Fabienne Kochert (F)

French Association of Ambulatory Paediatrics, 33400 Talence, France.

Isabelle De Beco (I)

College of General Medicine, 75017 Paris 8, France.

Sophie Mahut (S)

College of General Medicine, 75017 Paris 8, France.

Adrien Gantois (A)

Collège National des Sages-Femmes de France, 75015 Paris, France.

Chloé Barasinski (C)

Collège National des Sages-Femmes de France, 75015 Paris, France; Université Clermont Auvergne, CNRS, CHU Clermont-Ferrand, SIGMA, INSTITUT PASCAL, F63000 ClermontFerrand, France.

Karine Petitprez (K)

Guidelines Department, French National Authority for Health, 93200 Saint-Denis, France.

Anne-Françoise Pauchet-Traversat (AF)

Guidelines Department, French National Authority for Health, 93200 Saint-Denis, France.

Alcyone Droy (A)

Guidelines Department, French National Authority for Health, 93200 Saint-Denis, France.

Alexandra Benachi (A)

Service de Gynécologie Obstétrique, Hôpital Antoine Béclère, AP-HP, Université Paris-Saclay, 92140 Clamart, France; Collège National des Gynécologues Obstétriciens Français, 75002 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH